POLIVY is a prescription medicine used with other medicines (a rituximab product, cyclophosphamide, doxorubicin, and prednisone) as a first treatment for adults who have moderate to high risk diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL).
POLIVY is a prescription medicine used with other medicines (a rituximab product, cyclophosphamide, doxorubicin, and prednisone) as a first treatment for adults who have moderate to high risk diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL).
*Contact the Genentech Patient Resource Center at 1-877-436-3683 (Monday-Friday, 6am-5pm PST) for answers to your questions and to be connected to the right Genentech patient support service.
For adults with moderate to high risk previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL), POLIVY is a prescription medication used in combination with a rituximab product, cyclophosphamide, doxorubicin, and prednisone (R-CHP). It is administered by intravenous infusion every 21 days for six cycles. Learn more about preparing for treatment.
The serious to fatal side effects of POLIVY treatment include nerve problems in your arms and legs, infusion-related reactions, low blood cell counts, infections, rare and serious brain infections, tumor lysis syndrome, liver problems, and potential harm to your unborn baby. The most common side effects of POLIVY when used as a first treatment in DLBCL with the medicines rituximab product, cyclophosphamide, doxorubicin, and prednisone include nerve problems in arms and legs, nausea, tiredness or lack of energy, diarrhea, constipation, hair loss, redness and sores of the lining of the mouth, lips, throat, and digestive tract. POLIVY may lower your red or white blood cell counts and increase uric acid levels.
See important safety information as well as the full prescribing information.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.